Fig. 1 · Structure
Documents & Downloads
Butyryltimolol
β-adrenergic Blocker
Butyryltimolol is a β-adrenergic blocker that serves as an effective precursor to Timolol, enhancing its corneal penetration. This compound is utilized primarily in ocular research and therapeutic applications, where modulation of β-adrenergic activity is necessary for the treatment of glaucoma and other eye conditions. Its ability to improve drug delivery to target tissues makes it a valuable reagent for studies in ocular pharmacology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 106351-79-5 |
| Applications | β-adrenergic Blocker |
| Formula | C17H30N4O4S |
| Molecular Weight | 386.51 |
| SMILES | CCCC(O[C@@H](CNC(C)(C)C)COC1=NSN=C1N2CCOCC2)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.